Skip to main content

Doxorubicin News

Subsequent Breast Cancer Risk Higher for Child Cancer Survivors Receiving Doxorubicin

TUESDAY, Sept. 19, 2023 – For female survivors of childhood cancer, the risk for subsequent breast cancer (SBC) is more than twofold higher for those who receive a cumulative dose of 200 mg/m² or ...

FDA Grants Accelerated Approval to Lartruvo (olaratumab) for Advanced Soft Tissue Sarcoma

October 19, 2016 – The U.S. Food and Drug Administration today granted accelerated approval to Lartruvo (olaratumab) with doxorubicin to treat adults with certain types of soft tissue sarcoma (STS),...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Breast Cancer, Acute Lymphoblastic Leukemia, Thyroid Cancer, Ovarian Cancer, Multiple Myeloma, Lymphoma, Diffuse Large B-Cell Lymphoma, Cancer

Doxorubicin patient information at Drugs.com